Cambridge Investment Research Advisors, Inc. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$223
-99.9%
2,192
-8.2%
0.00%0.0%
Q3 2021$240,000
-26.2%
2,388
+4.1%
0.00%
-50.0%
Q2 2021$325,000
+46.4%
2,294
+3.0%
0.00%
+100.0%
Q1 2021$222,000
-16.2%
2,227
+3.8%
0.00%
-50.0%
Q4 2020$265,000
+16.2%
2,145
-8.5%
0.00%0.0%
Q3 2020$228,000
-41.4%
2,345
-6.0%
0.00%
-33.3%
Q2 2020$389,000
+8.1%
2,4950.0%0.00%0.0%
Q1 2020$360,000
-28.0%
2,495
+2.0%
0.00%
-25.0%
Q4 2019$500,0002,4450.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders